节点文献
大鼠侧脑室内注射五肽胃泌素对肺动脉压的影响
Effect of intracerebral ventricular injection of pentagastrin on the pulmonary arterial pressure of rats
【摘要】 目的:探讨五肽胃泌素对大鼠肺动脉压的影响及其所产生的中枢性作用。方法:实验于2003-10/2004-06在郧阳医学院机能实验中心完成。实验选用SD雄性大鼠56只,将大鼠随机分为6组。①生理盐水组(n=6):于侧脑室内注射生理盐水40μL连续观察30min。②侧脑室注射五肽胃泌素组(n=8):于大鼠侧脑室内注射五肽胃泌素0.2g/L。③生理盐水+五肽胃泌素组(n=6):于大鼠侧脑室预先注射生理盐水40μL,5min后从原导管注射五肽胃泌素0.2g/L,连续观察30min。④酚妥拉明+五肽胃泌素组(n=12):于大鼠侧脑室注射酚妥拉明((受体阻断剂)0.25g/L,连续观察30min肺动脉压,5min后从原导管注射五肽胃泌素0.2g/L。⑤普萘洛尔(β受体阻断剂)+五肽胃泌素组(n=12):于大鼠侧脑室预先注射普萘洛尔0.1g/L,5min后从原导管注射五肽胃泌素0.2g/L,连续观察30min。⑥阿托品(M受体阻断剂)+五肽胃泌素组(n=12):于大鼠侧脑室预先注射阿托品0.1g/L,5min后从原导管注射五肽胃泌素0.2g/L,连续观察30min。以肺动脉压为指标,在氨基甲酸乙酯麻醉、三碘季铵酚制动、呼吸机控制呼吸的SD大鼠上,观察给药前,给药后1,5,10,15,20,25,30min大鼠肺动脉压的变化。结果:56只大鼠均进入结果分析。①侧脑室注射五肽胃泌素组给药后5,10,15min大鼠肺动脉压明显高于给药前犤(20.6±1.0),(21.2±1.2),(20.4±1.0),(18.8±1.0),(18.7±0.8),(18.9±1.0)mmHg,P<0.01犦。②酚妥拉明+五肽胃泌素组大鼠在给药5,10,15min后肺动脉压明显低于生理盐水+五肽胃泌素组犤(18.6±1.1),(18.8±1.0),(18.6±1.1)mmHg;(20.1±1.0),(20.9±0.9),(21.1±1.0)mmHg,P<0.01犦。③普萘洛尔+五肽胃泌素组、阿托品+五肽胃泌素组大鼠在给药5,10,15min后肺动脉压与生理盐水+五肽胃泌素组比较,无明显差异犤(19.6±1.0),(20.4±1.1),(21.0±1.2)mmHg;(19.5±1.1),(20.6±1.2),(21.4±1.0)mmHg,P>0.05犦。结论:五肽胃泌素具有中枢性升高肺动脉压的作用,此作用可能部分由脑内β受体介导。
【Abstract】 AIM To study the effects of pentagastrin on the pulmonary arterial pressure in rats and discuss its central role.METHODS The experiment was carried out in the Functional Laboratory of Yunyang Medical College between October 2003 and June 2004.Fifty-six male SD rats were randomly divided into 6 groups ①saline groupn=6 rats received intracerebral ventricular injection of 40 μL saline and were observed for continuously 30 minutes.②intracerebral ventricular injection of pentagastrin groupn=8 rats received introcerebral ventricular injection of 20 g/L pentagastrin.③saline+pentagastrin groupn=6 rats received intracerebral ventricular injection of 40 μL salineand then they were injected with 0.2 g/L pentagastrin through previous catheter after 5 minutesand were observed for 30 continuous minutes.④phenolamine+pentagastrin groupn=12 rats received intracerebral ventricular injection of 0.25 g/L phenolaminealpha receptor blocking agentand the pulmonary arterial pressure was observed for 30 continuous minutesand then 0.2 g/L penta-gastrin was injected through previous catheter after 5 minutes.⑤propranololbeta receptor blocking agent+pentagastrin groupn=12 rats received intracerebral ventricular injection of 0.1 g/L propranololthen 0.2 g/L pentagastrin was injected through previous catheter after 5 minutesand they were observed for 30 continuous minutes.⑥atropineM receptor blocking agent+pentagastrin groupn=12 rats received intracerebral ventricular injection of 0.1 g/L atropineand then 0.2 g/L pentagastrin was injected through previous catheter after 5 minutesthey were observed for continuously 30 minutes.Taking pulmonary arterial pressure as the indexthe changes of pulmonary arterial pressure were observed before administration and 1510152025 and 30 minutes after administration in the SD ratswhich were anesthetized with ethyl carbamate and immobilized with syncurarineand whose breath was controlled with breathing machine.RESULTS All the 56 rats were involved in the analysis of results.①The pulmonary arterial pressure in the intracerebral ventricular injection of pen-tagastrin group was obviously higher at 510 and 15 minutes after adminis-tration than before administration20.6±1.021.2±1.220.4±1.018.8±1.018.7±0.818.9±1.0 mm HgP < 0.01.②The pulmonary arterial pressures at 510 and 15 minutes after adminis-tration in the phenolamine+pentagastrin group were remarkably lower than those in the saline+pentagastrin group18.6±1.118.8±1.018.6±1.1 mm Hg20.1±1.020.9±0.921.1±1.0 mm HgP < 0.01.③The pulmonary arterial pressures at 510 and 15 minutes after administration in the propranolol+pentagastrin group and atropine+pentagastrin group19.6±1.020.4±1.121.0±1.2 mm Hg19.5±1.120.6±1.221.4±1.0 mm Hg were not obviously different from those in the saline+pentagastrin groupP > 0.05.CONCLUSION Pentagastrin has an effect on the central increase of pulmonary arterial pressurewhich may be mediated by intracerebral beta receptor.
- 【文献出处】 中国临床康复 ,Chinese Journal of Clinical Rehabilitation , 编辑部邮箱 ,2005年27期
- 【分类号】R33
- 【下载频次】105